Cargando...

S100A8 is a Novel Therapeutic Target for Anaplastic Thyroid Carcinoma

CONTEXT: Anaplastic thyroid carcinoma (ATC) is one of the most deadly human malignancies. It is 99% lethal, and patients have a median survival of only 6 months after diagnosis. Despite these grim statistics, the mechanism underlying the tumorigenic capability of ATC cells is unclear. OBJECTIVE: S10...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Main Authors: Reeb, Ashley N., Li, Wen, Sewell, Will, Marlow, Laura A., Tun, Han W., Smallridge, Robert C., Copland, John A., Spradling, Kyle, Chernock, Rebecca, Lin, Reigh-Yi
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318889/
https://ncbi.nlm.nih.gov/pubmed/25423568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2988
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!